<DOC>
	<DOCNO>NCT01077661</DOCNO>
	<brief_summary>An open label , multi-centre , non-interventional post-marketing surveillance ( PMS ) monitor safety effectiveness Nebivolol administer Korean patient accord prescribe information</brief_summary>
	<brief_title>Regulatory Nebilet PMS</brief_title>
	<detailed_description>An open label , multi-centre , non-interventional post-marketing surveillance ( PMS ) monitor safety effectiveness Nebivolol administer Korean patient accord prescribe information Nebivolol administer Hypertension Chronic heart failure ( CHF ) patient describe prescribe information Nebivolol physician 's decision .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>All subject must satisfy follow criterion PMS entry accord KFDA PMS regulation : Subjects indication prescribe information Subjects administrate Nebivolol physician 's decision Subjects contraindication accord prescribe information</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Nebivolol</keyword>
	<keyword>PMS ( post-marketing surveillance )</keyword>
</DOC>